Market Exclusive

Meridian Bioscience (NASDAQ:VIVO) reported earnings of $0.15 per share beating Walls Streets expectations.

Meridian Bioscience (NASDAQ:VIVO) reported Q1 2018 earnings this Morning, coming in at $0.15 per share, beating Wall Street’s estimates of $0.14 per Share. Revenue for the quarter came in at $52.30 million beating analyst estimates of $49.00 million Recent Insider Trading for Meridian Bioscience (NASDAQ:VIVO)

Dividend History for Meridian Bioscience (NASDAQ:VIVO)

Recent Trading for Meridian Bioscience (NASDAQ:VIVO) Shares of Meridian Bioscience closed the previous trading session at 15.25 up +0.45 3.04% with 14.701000213623047 shares trading hands.

Exit mobile version